Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11026
PUT
Ceragon Networks
CRNT
$192M
| $133K | ﹤0.01% |
28,500
+24,400
| +595% | +$82.3K |
2023 Q1
7 quarters
|
|
11027
HCI Group
HCI
$2.33B
| $133K | ﹤0.01% |
1,142
-82,395
| -99% | -$9.38M |
2021 Q1
15 quarters
|
|
11028
PUT
Clarus
CLAR
$129M
| $133K | ﹤0.01% |
29,500
+8,500
| +40% | +$38.1K |
2022 Q2
10 quarters
|
|
|
SRTA
11029
PUT
Strata Critical Medical Inc
SRTA
$407M
| $133K | ﹤0.01% |
31,300
+4,800
| +18% | +$18.3K |
2021 Q1
15 quarters
|
|
11030
CALL
Vanguard Extended Market ETF
VXF
$30.1B
| $133K | ﹤0.01% |
700
-6,400
| -90% | -$1.23M |
2021 Q3
13 quarters
|
|
|
WNS
11031
CALL
DELISTED
WNS Holdings
WNS
| $133K | ﹤0.01% |
2,800
+400
| +17% | +$19.7K |
2022 Q4
8 quarters
|
|
|
LEGT
11032
DELISTED
Legato Merger Corp III
LEGT
| $133K | ﹤0.01% |
+12,890
| New | +$132K |
2024 Q4
0 quarters
|
|
11033
PUT
HUTCHMED
HCM
$2.37B
| $133K | ﹤0.01% |
9,200
+8,100
| +736% | +$145K |
2022 Q4
8 quarters
|
|
|
CRT
11034
Cross Timbers Royalty Trust
CRT
$69.8M
| $132K | ﹤0.01% |
+13,379
| New | +$138K |
2024 Q4
0 quarters
|
|
|
CSR
11035
PUT
Centerspace
CSR
$914M
| $132K | ﹤0.01% |
2,000
-500
| -20% | -$35.2K |
2023 Q4
4 quarters
|
|
|
CWEN.A
11036
CALL
DELISTED
Clearway Energy Class A
CWEN.A
| $132K | ﹤0.01% |
5,400
-400
| -7% | -$10.4K |
2022 Q1
11 quarters
|
|
11037
iShares MSCI China A ETF
CNYA
$194M
| $132K | ﹤0.01% |
4,727
+1,774
| +60% | +$52.6K |
2023 Q1
7 quarters
|
|
|
IMA
11038
ImageneBio Inc
IMA
$49.9M
| $132K | ﹤0.01% |
6,697
-7,054
| -51% | -$143K |
2021 Q1
15 quarters
|
|
11039
CALL
Douglas Emmett
DEI
$1.61B
| $132K | ﹤0.01% |
7,100
-2,400
| -25% | -$44.7K |
2022 Q4
8 quarters
|
|
|
ASG
11040
Liberty All-Star Growth Fund
ASG
$322M
| $132K | ﹤0.01% |
+23,286
| New | +$134K |
2024 Q4
0 quarters
|
|
|
WCLD
11041
PUT
WisdomTree Cloud Computing Fund
WCLD
$292M
| $131K | ﹤0.01% |
3,500
+1,300
| +59% | +$47.3K |
2022 Q3
9 quarters
|
|
11042
CALL
Orion
OEC
$322M
| $131K | ﹤0.01% |
8,300
-5,700
| -41% | -$96.3K |
2022 Q3
9 quarters
|
|
11043
CALL
Atlas Lithium Corp
ATLX
$69.8M
| $131K | ﹤0.01% |
20,700
+5,600
| +37% | +$42.6K |
2023 Q4
4 quarters
|
|
11044
CALL
Tradr 2X Long Innovation ETF
TARK
$16.7M
| $131K | ﹤0.01% |
3,000
-5,400
| -64% | -$219K |
2023 Q1
7 quarters
|
|
11045
Breakwave Dry Bulk Shipping ETF
BDRY
$36M
| $131K | ﹤0.01% |
21,498
+18,251
| +562% | +$139K |
2022 Q4
8 quarters
|
|
11046
CALL
Sibanye-Stillwater
SBSW
$6.89B
| $131K | ﹤0.01% |
39,600
+4,000
| +11% | +$16.8K |
2019 Q1
23 quarters
|
|
11047
BlackRock MuniYield Quality Fund III
MYI
$1.15B
| $131K | ﹤0.01% |
+11,831
| New | +$135K |
2024 Q4
0 quarters
|
|
11048
PUT
CNA Financial
CNA
$12.5B
| $131K | ﹤0.01% |
2,700
-4,500
| -63% | -$220K |
2022 Q3
9 quarters
|
|
11049
PUT
Voyager Therapeutics
VYGR
$145M
| $130K | ﹤0.01% |
23,000
+14,200
| +161% | +$91.5K |
2022 Q4
8 quarters
|
|
11050
PUT
Sabesp
SBS
$22.9B
| $130K | ﹤0.01% |
46,924
-6,188
| -12% | -$18.9K |
2024 Q1
3 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.